Overview

Efficacy of Vildagliptin Versus Metformin in Poly Cystic Ovary Syndrome

Status:
Recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
Polycystic ovary syndrome (PCOS) is an endocrine disorder that affects approximately 10-20% of women of reproductive age, Management strategies for PCOS include lifestyle modifications such as diet and physical activity that are the first-line approach to treatment; however, they are reported to be minimally effective in reducing weight or treating PCOS-related symptoms.Pharmacological options are also available; however, they are not explicitly approved for PCOS treatment as they have been primarily used to treat other conditions such as T2DM
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
October 6 University
Treatments:
Metformin
Vildagliptin